Cantor Capital Commentary

The most recent commentary notes are detailed below, for older reports please select the archive.

Our commentary notes are also freely available to all by email.

To register please fill in the enclosed “Commentary Registration” form.

Email: sales@cantorcapital.com Tel: +44 (0) 20 7894 8800.

Silver & Gold Technical Analysis

Tuesday, 19 February 2013


Euro Debate Banner
Tuesday, February 19, 2013, Marketing Communication
Silver, Monthly (Gold Overlay)
Monthly Chart
The monthly graph above shows the stellar performance of Gold and Silver over the past 25 years. Silver is the OHLC prices above in Blue, Gold prices are the Gold line.
This graph is all the more extraordinary as this is on a semi-log scale. Detailing how the gains posted in recent years have kept pace with the early gains posted 2000-2007.
This graph does detail however an interesting difference between Silver and Gold in recent years. Silver came off hard into the wider market sell-off into 2008, while Gold barely retraced.
Then again from the highs in 2011 Silver has again retraced quite sharply, detailed more with the weekly graph below.
Silver, Weekly (Gold Overlay)
Weekly Chart
Over the Weekly timescale we can again see this out-performance by gold in times of wider market turmoil.
Both Gold and Silver prices gained sharply from the lows in 2008, to post multi year highs. The graph details how Silver has since come off over 50% from these highs, red lines, while Gold in comparison has not breached its 23.6% retracement level, not graphed. These retracements are calculated from the 2008 lows to the all time highs. Detailing how the wider market understandably turned to Gold in times of market uncertainty while Silver has been more closely linked to industrial trends.
On the Silver price we post a possible Elliott Wave count, where the moves from 2008-2012 seem to be a relatively straightforward impulse move higher, followed by an abc correction lower. This count follows the basic Elliott Wave rules where Wave 4 does not overlap with Wave 1, Wave 3 is not the shortest, and interestingly the abc correction has found support from the end of Wave 4. Which is often the case.
As a result this Wave 4 low at 26.39 is seen as pivotal for the medium term. While this level holds the outlook is positive expecting a new bullish 5 wave impulse to form in the coming quarters. Whereas a break below would suggest the correction has further to go.
Also on the graph we flag up how silver has retraced 50% of this move and how the upper 38.2% area seems to be offering resistance. Setting up a medium term trading range between the pivotal medium term support at 26.39 and the 38.2% highs at 34.11.
Gold, Daily
Silver, Daily
Daily Chart
Drilling down to the daily charts we can see that over the recent moves Gold has just marginally under-performed, upper graph.
As Gold has moved down to the lower end of its recent trading range, red region, and has broken its 61.8% retracement levels, calculated from the May 2012 lows to the October 2012 highs, red lines. While Silver in comparison has held its comparable 61.8% level and has not posted fresh lower lows in February. Also Silver remains mid range of its comparable trading region.
We would suggest that the pivotal medium term support detailed on the weekly graph may be the cause for Silver not matching Gold lower in recent days.
Traders therefore could migrate to Silver in the near term looking at the major support level as offering decent risk/reward on buying the commodity now, looking for a near term move to the 34.12 resistance area. With any breaks above the 34.12 area seen as offering up considerable upside potential indicating the multi-year bullish trend is set to resume.
Technical Analysis Seminar, February 26th, 2013
Our next seminar will be on Elliott Wave Analysis.  The presentation will be at our office at One Churchill Place, Canary Wharf, London.
Elliott Wave Analysis is one of the more esoteric technical tools and as a result it can be open to abuse and criticism. However the basic fundamentals, which will be covered in this seminar, can provide a useful framework for trading. Registration is freely available to all, not just Cantor Index clients. If you would like to register for what we hope will be an informative and enjoyable evening, please click on the banner above to open the registration page, or alternatively please contact us by email and we can add you to the guest list.
Contact Us
  • For Spread Bet Sales:- 0044 (0) 207 894 8800
  • For CFD Sales/Traders:- 0044 (0) 207 894 8883
  • Email:- sales@cantorcapital.com
Graphs
Depending on your email settings the images contained in this note may not be downloaded correctly on the first viewing. To view a web version please click here, Web version. Graph images are created on Bloomberg, and remain under copyright to Bloomberg.
Unsubscribing From E-mails
If you would like to be removed from all Cantor Capital Commentary e-mails then please click on the ‘Update Preferences’ link on the header, or the ‘Edit your subscription’ link on the footer and select the ‘Unsubscribe’ link at the bottom of this page that appears. This will remove your e-mail from all Cantor Capital Commentary distribution lists.
Regulatory Disclaimer
This market commentary note (“note”) has been issued by Cantor Fitzgerald Europe (“CFE”), which is authorised and regulated by the Financial Services Authority (“FSA”). Cantor Index is a trading name of (CFE). This note is defined by the FSA as a marketing communication. This note has been prepared and distributed for information purposes only and represents the personal views and opinions of the sender. This note is not “investment research”, a “research recommendation” or a product of the Research Department. Please be aware that the CFE Research Department may issue a formal recommendation and target price on the stocks mentioned, which may differ from the opinion given here.  This note may contain information obtained by CFE from third parties; the source of information will usually be disclosed.  CFE makes no representation and gives no warranty as to the accuracy or completeness of the contents of this note. Any person placing reliance upon this note does so at their own risk. Investors should consider this note as only a single factor in making their investment decision. The investment discussed in this note may be unsuitable for investors depending on their specific investment objectives and financial position. CFE, its officers, employees and affiliates shall not be liable to any person in any way whatsoever for any losses, costs or claims howsoever arising from any inaccuracies or omissions in this note or any reliance on this note. The recipient is strongly recommended to see independent legal, tax and financial advice. Past performance is not necessarily a guide to future performance. Income from investments may fluctuate The price or value of the investments to which this note relates; either directly or indirectly, may fall or rise against the interest of investors.
This note should not be considered to be a solicitation nor an offer of advice for the purposes of the sale or purchase of any security, investment or derivative.  The information contained in this note is not intended to form the basis of any investment decision and should not be considered a recommendation by CFE or any other person in relation to any of the companies, stock, commodities, currencies or other markets mentioned / referred to in this note. All the information contained herein is based upon information available to the public and has been obtained from sources believed to be reliable. However, the information contained in this note has not been verified by CFE and CFE undertakes no obligation to provide recipients of this note with any additional information or any update to or correction of the information contained in this note. This note is provided by CFE and may be forwarded unamended and in its entirety. This note may not be used in whole or in part to create any other work. All rights reserved.
CFE is authorised and regulated by the FSA under Firm Reference Number 149380.   CFE - FSA Register Information: http://www.fsa.gov.uk/register/firmBasicDetails.do?sid=61341
Registered in England No. 02505767
Registered Address: 17 Crosswall, London, EC3N 2LB
Risk Warning
Trading CFDs carries a high level of risk to your capital and is not suitable for all customers. Furthermore, margined products use leverage to increase the level of exposure to the product, and as a result your losses may substantially exceed your initial deposit and require you to make additional deposits at short notice. Prior to trading leveraged CFDs, you should carefully consider your investment objectives, experience and risk appetite and should not invest money that you cannot afford to lose.
Spread Bets are leveraged products placing your capital at risk. Losses can quickly exceed your initial deposit and thus require you to make additional deposits at short notice to maintain your positions. Leveraged products are not suitable for all customers. Please ensure you understand the risks involved before opening an account. You should ensure you fully understand the risks and seek independent financial advice if in doubt.
CFE provides an execution only service and does not offer investment advice.
These products are not intended for people under the age of 18 or for US residents.
The distribution of this note in other jurisdictions may be restricted by law and persons into whose possession this note comes should inform themselves about and observe any such restrictions. By accepting this note you agree to be bound by the foregoing instructions.

 

Risk WarningFull Risk Warning

Spread Bets are leveraged products placing your capital at risk. Losses can quickly exceed your initial deposit and thus require you to make additional deposits at short notice to maintain your positions. Leveraged products are not suitable for all customers. Please ensure you understand the risks involved before opening an account. Cantor Index provides an execution only service and does not offer investment advice. You should ensure you fully understand the risks and seek independent financial advice if necessary. These products are not intended for people under the age of 18 or for US residents.